维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="GARRISON LP"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Global eradication of measles:an epidemiologic and economic evaluation显示文摘	Levin A Burgess C Garrison LP Jr		0，，1：	1
2	Epidermal growth factor receptor genomic variation in NSCLC patientsreceiving tyrosine kinase inhibitor therapy: a systematic re- view and meta - analysis 显示文摘	Carlson J J Garrison LP Ramsey SD	2009	J Cancer Res Clin Oncol2009，135，11：	1
3	A flexible ap- proach to evidentiary standards for comparative effectiveness re- search 显示文摘	Garrison LP Jr Neumann P J Radensky P	2010	Health Aft ( Millwood)2010，29，10：	1
4	Economic evaluation of capecitabine as adju- vant or metastatic therapy in eolorectal cancer显示文摘	Best JH Garrison LP	2010	Expert Rev Phar- macoecon Outcomes Res2010，10，2：	1
5	The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007)显示文摘	Wong WB Ramsey SD Barlow WE Garrison LP Jr Veenstra DL	2012	Contemp Clin Trials2012，33，6：	1
6	The qual-ity of life of patients with end-stage renal disease显示文摘	EVANS RW MANNINEN DL GARRISON LP	1985	N Engl J Med1985，312，2：	1
7	Cost-effectiveness analysis of trastuzumab in the adjuvant setting for treatment of HER2-positive breast cancer显示文摘	Garrison LP Jr Lubeck D Lana D	2007	Cancer2007，110，3：	1
8	Linking payment to health outcomes : a taxonomy and examination of performance- based reimbursement schemes between healthcare payers and manufacturers显示文摘	Carlson JJ Sullivan SD Garrison LP	2010	Health Policy2010，96，13：	1
9	The cost effectiveness of mycophenolate mofetil in the first year after prima-ry cadaveric transplant显示文摘	SULLIVAN SD GARRISON LP JR BEST JH	1997	J Am Society Nephrol1997，，8：	1
10	Assessing a structured, quantitative health outcomes approach to drug risk-benefit analysis显示文摘	Garrison LP Jr Towse A Bresnahan BW	2007	Health Aft2007，26，3：	1
11	The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer显示文摘	Carlson J J Garrison LP Ramsey SD Veenstra DL	2009	Value Health2009，12，1：	1
12	Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model显示文摘	Sander B Nizam A Garrison LP		0，，02：	1
13	Link - ing payment to health outcomes : a taxonomy and examination of performance -based reimbursement schemes between healthcare payers and manufacturers 显示文摘	Carlson JJ Sullivan SD Garrison LP	2010	Health Policy2010，96，：	1
14	Linking payment to health outcomes: a taxonomy and examination of performance- based reimbursement schemes between health care payers and manufacturers显示文摘	Carlson JJ Sullivan SD Garrison LP	2010	Health Policy2010，96，3：	1
15	The quality of life of pationts with end-stage renal failure显示文摘	Evans RW Manninen DL Garrison LP	1985	N Engl J Med1985，312，：	1
16	Scheduling of measles vaccination in low-income countries:Projections of a dynamic model显示文摘	Bauch CT Szusz E Garrison LP	2009	Vaccine2009，27，31：	1
17	The quality of life of patients with end stage renal failure显示文摘	EVANS RW MANNINEN DL GARRISON LP	1985	N Engl J Med1985，312，：	1
18	The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in nonsmall-cell lung cancer显示文摘	CARLSON JJ GARRISON LP RAMSEY SD	2009	Value Health2009，12，1：	1
19	Economic evaluation of influenza pandemic mitigation strategies in the United States using a stochastic microsimulation transmission model 显示文摘	Sander B Nizam A Garrison LP	2009	Value Health2009，12，2：	1
20	Economic evaluation of influ- enza pandemic mitigation strategies inthe United States using a stochas- tic microsimulation transmission 'model 显示文摘	Sander B Nizam A Garrison LP	2009	Value Health2009，12，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示